fda approv iqo market modest valuat
upsid pmi
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research may
estim apr
price data may
rate updat may
currenc amount express
methodolog valu compani
altria pmi abl
market iqo compani market-lead heat
tobacco technolog devic fda
approv sale product long-await
decis judgment pmi applic
market iqo modifi risk product howev
fda decis still pend altria market
distribut iqo pmi retain
intellectu properti right two compani share
revenu gener
iqo sale undisclos
proport think econom benefit
develop greater pmi altria
estim news add pmi intrins valu
line market earli reaction howev mere
offset effect weak first quarter reiter
fair valu estim wide-moat rate pmi
fda said believ iqo produc lower level
toxin cigarett toxin detect
lower found cigarett significantli
also sanguin likelihood product would
attract younger consum nevertheless iqo
regul tobacco product
view posit tobacco compani strict
regul like keep barrier entri high
carri extens analysi diffus path
heat tobacco use bass quantit model
rodger qualit model believ
similar incom smoke popul
cultur differ adopt like
follow path europ rather asia henc
absenc modifi risk claim expect categori
market share gain limit four year
commerci categori share itali
lower eu market albeit shorter
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
analyst note equiti incom model ebit line
middleton michel wine estat nu mark philip morri capit
hold interest world largest brewer anheuser-busch
inbev tobacco subsidiari altria hold lead posit
cigarett smokeless tobacco unit state number-two
spot machine-mad cigar compani marlboro brand lead
cigarett brand share
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
cigarett figur distort revenu
gener devic low
margin estim devic gener ebit margin
full price approxim break-even discount
price sale littl effect valuat
stock
assumpt requir estim margin
much depend rate excis tax impos
heatstick bullish scenario heatstick
tax lower rate cigarett perhap similar
level consum good encourag migrat
cigarett case retail price line
cigarett margin like accru
manufactur base case assumpt howev
heatstick tax tobacco product
consist fda regul categori
tobacco product assum cigarette-typ tax burden
seem unlik heatstick replic margin
premium cigarett medium term given lack
visibl adopt path product seem
unlik pmi altria build manufactur facil
 categori grow scale support
invest therefor cost ship finish
product mean cost good sold
structur higher elsewher
assum ebit margin low convict given
wide rang assumpt stage estim
sale iqo gener million
increment ebit pmi like immateri
altria ebit
mani assumpt behind iqo cash flow
forecast amount littl educ
estim first time roll-out altria begin
test market iqo atlanta georgia summer
expect broader roll-out product faster
 earlier market unrealist
expect multi-st roll-out end
second major assumpt volum impact
heatstick take account market share
europ benchmark adopt assum
annual declin rate total market estim
heatstick could achiev volum billion stick
would entir increment pmi would
complex assumpt revenu share
two compani use assumpt market
share annual price
cigarett segment encourag migrat assum
revenu per pack excis tax
estim revenu heatstick could reach
billion base cost-plu revenu
share model bulk revenu would accru
pmi pmi carri cost good sold full research
develop expens cost ship product
 altria assum cost market
distribut well higher master settlement
agreement fda user fee revenu split could
pmi realiti agreement like
favor altria order neutral econom
impact cannib cigarett busi
assum equal revenu share therefor pmi could
benefit revenu increas million
howev expect altria revenu heatstick
larg come expens heavier volum declin
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
incom equiti invest
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
